Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Iron infusion after C-Section may cut depression risk

NCT ID NCT06833788

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares IV iron to oral iron pills for treating moderate anemia after a C-section. The goal is to see if better iron levels can reduce the risk of postpartum depression. About 2,860 women will take part, and their mood will be checked 8 weeks after delivery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Ferric carboxymaltose (IV iron) and Timoférol (oral iron)
What this could lead to
If it works, this could show that treating anemia after C-section with IV iron lowers the chance of postpartum depression.
What could go wrong
This is a Phase 4 trial, but it's still recruiting and results aren't in yet. The benefit may be small or not apply to all women, and IV iron carries rare risks like allergic reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

About 2,860 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Oct 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Pre-inclusion criteria: * Age ≥18 years * Caesarean delivery (elective or in emergency) * Gestational age at delivery ≥ 32 weeks * 8.0 g/dL ≤ postoperative Hb level ≤ 10.0 g/dL measured within 72 hours postpartum * Informed consent form signed * Hospitalization in the postpartum maternity ward * National social security coverage including AME Inclusion criteria: * Ferritinemia ≤ 100 ng/mL OR transferrin saturation ≤ 20% measured after postoperative Hb level measurement * EPDS score in the immediate postpartum \<11 with a "never" answer to question n°10 Exclusion Criteria: * Stillbirth or neonatal death * Last body weight available before inclusion (measured at the end of pregnancy or in postpartum) \< 35kg or \> 100kg * Biermer disease * Hemochromatosis * Homozygous sickle cell disease or thalassemia * Chronic iron supplementation (outside pregnancy) * Known hypersensitivity or allergy to the studied drugs (IV or oral iron) * Contra-indication to the studied drugs (IV or oral iron) * Severe asthma (with daily background treatment) * Any known severe renal or liver disorder * Active acute infection * Diagnosis of schizophrenia or physical and intellectual state incompatible with a reliable self-evaluation * Women currently treated with medication or with Electro Convulsion Therapy (ECT) for depression or bipolar disorders * Participation in another clinical trial involving an intervention with the following risks: * A change (increase or decrease in value) in Haemoglobin measured at 2 months postpartum OR * A change in EPDS score measured at 2 and 6 months postpartum OR * A trial exploring an intervention with a specific anaphylactic risk (reported as a potential adverse events in the protocol of the other trial) administered during the postpartum hospitalization period. * Poor understanding of the French language * Legal protection (curatorship or tutorship)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Postpartum depression (PPD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU Armand -Trousseau, AP-HP Service d'anesthésie-réanimation chirurgicale

    RECRUITING

    Paris, 75012, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.